Current partner codePEPTIDESDE
NCT04916665·Not applicable·OBSERVATIONAL

Bridging Intestinal Failure With Teduglutide - a Case Report

Status

Completed

Phase

Not applicable

Enrollment

1

Locations

1

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.

Interventions

Treatment arms and agents.

DRUG

Teduglutide

bridging intestinal failure with teduglutide until reconstruction

Timeline

From registration to results.

  1. First posted

    Jun 7, 2021

  2. Study start

    Jan 1, 2019

  3. Primary completion

    Dec 31, 2019

  4. Study completion

    Dec 31, 2019

  5. Results posted

    Not reported

  6. Registry updated

    Jun 7, 2021

Outcomes

What the study measures.

Primary outcomes

enteral autonomy (complete discontinuation of parenteral support)

Time frame · 6 months

observe if enteral autonomy may be achieved before reconstruction

Secondary outcomes

Not reported in the indexed record.

Eligibility

Who can take part.

Minimum age
Not reported
Maximum age
Not reported
Sex
MALE
Healthy volunteers
Not reported

Inclusion Criteria: short bowel syndrome Exclusion Criteria: * \<18 years

Study locations

1 registered sites.

Austria. Showing up to 24 locations stored in the fast local snapshot.

Medical University of Vienna

Vienna, Austria

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Teduglutide.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.